Gilead Sciences Inc (GILD)
77.01
+0.48
(+0.63%)
USD |
NASDAQ |
Jul 26, 16:00
77.01
0.00 (0.00%)
After-Hours: 20:00
Gilead Sciences Price: 77.01 for July 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 25, 2024 | 74.75 | 77.34 | 74.38 | 76.53 | 10.07M |
| Jul 24, 2024 | 71.66 | 73.60 | 71.42 | 73.50 | 6.600M |
| Jul 23, 2024 | 71.95 | 72.29 | 70.78 | 71.17 | 4.502M |
| Jul 22, 2024 | 72.89 | 73.32 | 72.02 | 72.41 | 6.421M |
| Jul 19, 2024 | 73.51 | 73.74 | 71.96 | 72.56 | 5.572M |
| Jul 18, 2024 | 72.60 | 74.92 | 72.50 | 73.51 | 8.120M |
| Jul 17, 2024 | 72.01 | 73.98 | 72.01 | 73.30 | 7.220M |
| Jul 16, 2024 | 70.33 | 72.05 | 70.33 | 71.64 | 5.130M |
| Jul 15, 2024 | 70.40 | 71.24 | 70.21 | 70.81 | 7.569M |
| Jul 12, 2024 | 70.25 | 70.68 | 69.91 | 69.96 | 5.101M |
| Jul 11, 2024 | 68.22 | 70.30 | 68.14 | 69.97 | 9.598M |
| Jul 10, 2024 | 67.83 | 68.86 | 67.65 | 68.75 | 4.102M |
| Jul 09, 2024 | 67.10 | 67.97 | 66.34 | 67.76 | 5.364M |
| Jul 08, 2024 | 67.86 | 68.18 | 67.03 | 67.55 | 5.747M |
| Jul 05, 2024 | 66.62 | 66.93 | 66.01 | 66.69 | 4.212M |
| Jul 03, 2024 | 68.24 | 68.33 | 66.58 | 66.59 | 3.996M |
| Jul 02, 2024 | 68.30 | 68.49 | 67.58 | 68.40 | 4.846M |
| Jul 01, 2024 | 68.63 | 69.99 | 68.50 | 68.64 | 5.251M |
| Jun 28, 2024 | 68.83 | 69.00 | 68.06 | 68.61 | 9.590M |
| Jun 27, 2024 | 69.14 | 69.59 | 68.52 | 68.83 | 7.176M |
| Jun 26, 2024 | 69.19 | 70.23 | 68.90 | 69.31 | 5.795M |
| Jun 25, 2024 | 70.64 | 71.48 | 69.52 | 69.61 | 9.401M |
| Jun 24, 2024 | 71.00 | 72.07 | 70.56 | 70.73 | 10.92M |
| Jun 21, 2024 | 71.55 | 72.18 | 69.56 | 70.67 | 31.30M |
| Jun 20, 2024 | 65.03 | 69.47 | 64.86 | 68.49 | 25.06M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
56.65
Minimum
Dec 30 2020
89.47
Maximum
Dec 08 2022
70.29
Average
68.36
Median
Price Benchmarks
| AbbVie Inc | 185.15 |
| Bristol-Myers Squibb Co | 50.40 |
| Amgen Inc | 334.71 |
| Pfizer Inc | 30.78 |
| Arcus Biosciences Inc | 15.82 |
Price Related Metrics
| PE Ratio | 213.92 |
| PS Ratio | 3.519 |
| Price to Book Value | 5.470 |
| Price to Free Cash Flow | 12.23 |
| Earnings Yield | 0.47% |
| Market Cap | 95.94B |
| Operating PE Ratio | 15.02 |
| Normalized PE Ratio | 19.73 |